Clinical Trials Directory

Trials / Completed

CompletedNCT06064799

GCF miRNA-223 , -214 Levels in Smokers and Nonsmokers Periodontitis Patients

Expression of microRNA-223 and microRNA-214 in Gingival Crevicular Fluid of Smoker and Nonsmoker Periodontitis Patients, an Observational Diagnostic Accuracy Study

Status
Completed
Phase
Study type
Observational
Enrollment
42 (actual)
Sponsor
Fayoum University · Academic / Other
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Accepted

Summary

Objective: Periodontitis is a multifactorial disease that affects a wide range of populations. However, its pathogenesis remains unclear. miRNAs are now considered potential diagnostic markers for many inflammatory diseases. Thus, the aim of this study was to assess the expression of microRNA-223(miRNA-223) and microRNA-214 (miRNA-214) in gingival crevicular fluid (GCF) of smoker and nonsmoker with periodontitis. Materials and Methods: We conducted a prospective study among 42 participants: 14 healthy controls, 14 nonsmoker periodontitis participants, and 14 smoker with periodontitis. Eligibility criteria for inclusion were consecutive adults, aged 20-60 years, with stage III periodontitis grade B/C and no systemic diseases. All consenting participants had gingival crevicular fluid samples collected after diagnosis to assess miRNA-214 and -223 by quantitative real-time polymerase chain reaction assay.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTmiRNA-223 & -214 detectionmiRNA-223 \& -214 detection in GCF samples by PCR kits

Timeline

Start date
2023-01-01
Primary completion
2023-06-30
Completion
2023-06-30
First posted
2023-10-03
Last updated
2023-10-03

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06064799. Inclusion in this directory is not an endorsement.